NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
created: Sept. 28, 2025, 8 p.m. | updated: Sept. 29, 2025, 7:58 p.m.
New York, New York--(Newsfile Corp. - September 28, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE: NVO) and certain of its officers.
or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
If you suffered a loss in Novo Nordisk you have until September 30, 2025, to request that the Court appoint you as lead plaintiff.
There is No Cost to YouWe represent investors in class actions on a contingency fee basis.
Why Bronstein, Gewirtz & GrossmanBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.
4 weeks, 1 day ago: News Ticker - markets.businessinsider.com